Cutaneous small-vessel vasculitis following hysterosalpingo-foam sonography (HyFoSy).

Ultrasound Obstet Gynecol

SEMEAR Fertilidade, Reproductive Medicine, Ribeirão Preto, Brazil.

Published: December 2019

We present a case of diffuse skin immune reaction, diagnosed as cutaneous small-vessel vasculitis, following assessment of tubal patency by contrast ultrasound, which appears to be the first reported case of hypersensitivity reaction to sonographic tubal patency testing, based on a literature search. A 32-year-old woman presented with non-thrombocytopenic palpable purpura the day after assessment of tubal patency by two-/three-dimensional hysterosalpingo-foam sonography (HyFoSy) using ExEm® Foam. During real-time ultrasound, the observer identified flow in only the right tube when using saline with air as contrast medium; however, the same observer identified flow in both tubes after injecting ExEm Foam and the woman left the clinic without any complications. The next day, the patient was admitted with a complaint of a red-purple skin rash noticed the same morning, associated with moderate leg pain. Slow-motion analysis of the recorded videos and three-dimensional ultrasound datasets showed previously unnoticed venous intravasation of ExEm Foam into the myometrial vessels. Palpable purpura is typically found in vasculitis as a result of extravasation of red cells outside the inflamed blood vessel. This previously unreported side effect of tubal patency testing by HyFoSy, its potential rare organ consequences, as well as unknown consequences of venous intravasation by foam, should be included in the informed consent prior to the examination. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Download full-text PDF

Source
http://dx.doi.org/10.1002/uog.20372DOI Listing

Publication Analysis

Top Keywords

tubal patency
16
cutaneous small-vessel
8
small-vessel vasculitis
8
hysterosalpingo-foam sonography
8
sonography hyfosy
8
assessment tubal
8
patency testing
8
palpable purpura
8
observer identified
8
identified flow
8

Similar Publications

Risk of adverse pregnancy outcomes after abnormal hysterosalpingography.

Hum Fertil (Camb)

December 2025

Assisted Reproductive Technologies Unit, Department of Obstetrics and Gynecology, Barzilai University Medical Center, Ashkelon, Israel.

Objective: To investigate the association between an abnormal hysterosalpingogram (HSG) and obstetrical and neonatal outcomes.

Design: A retrospective cohort study comparing outcomes between women with normal versus abnormal tubal patency and uterine cavity on HSG.

Results: Among 2181 women included in the study, 494 (22.

View Article and Find Full Text PDF

: Hysterosalpingography (HSG) is pivotal in delineating tubal pathology, but is associated with pain and exposure to ionizing radiation. This study investigated which reproductive factors predict HSG-identified tubal pathology. : From May 2016 to August 2023, 3322 infertile females with HSG (mean age 33.

View Article and Find Full Text PDF

Background: Chronic endometritis (CE), frequently asymptomatic, is associated with female infertility. Fallopian tube obstruction (FTO) is also one of the factors contributing to female infertility. More than 90% of cases of proximal FTO can be successfully treated after fallopian tubal recanalization (FTR) and the spontaneous pregnancy rate of treated women after FTR is only about 30%.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the occurrence of contrast-induced nephropathy (CIN) in 65 women who underwent hysterosalpingography (HSG) for infertility evaluations.
  • The results showed a CIN rate of 12.3% among participants, with a significant difference in baseline serum creatinine levels between women with and without CIN.
  • Baseline serum creatinine levels were identified as an independent risk factor for developing CIN following the HSG procedure.
View Article and Find Full Text PDF

Prevalence of contrast intravasation in HyCoSy/HyFoSy. Results of a multicenter study and systematic review of the literature with meta-analysis.

Eur J Obstet Gynecol Reprod Biol

February 2025

Centro Integrato di Procreazione Medicalmente Assistita (PMA) e Diagnostica Ostetrico-Ginecologica, Policlinico Universitario Duilio Casula, Monserrato, University of Cagliari, Cagliari, Italy.

Objective: To determine the frequency of uterine contrast agent intravasation during HyCoSy/HyFoSy for assessing tubal patency in infertile women.

Methods: Prospective observational multicenter study performed in nine European university hospitals, comprising a series of non-consecutive women who underwent HyFoSy (ExEm foam) for tubal patency assessment in the context of infertility between May 2016 and December 2022. All examinations were performed using the same scanning protocol.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!